Solutions to make life better

In August 2017, Renew acquired the Intelesens business, and its portfolio of intelligent, wearable, non-invasive, vital signs monitoring devices for the hospital and home patient monitoring markets including the Zensor™ device and Zensor™+ Analysis Software.

 

In 2020, the LifeSignals Group acquired the connected health assets from Renew, including the Zensor™ device and Zensor™+ Analysis Software.  With its wide-ranging assets, LifeSignals plan to accelerate the global adaptation of clinical-grade wireless biosensors and platforms by working with leading healthcare service providers, thereby improving healthcare delivery to currently underserved populations.